Rite Aid Corp.

The US Federal Trade Commission contends that a district court got it wrong in finding that Forest Laboratories, Inc. ’s side deals with generic manufacturers did not constitute unjustifiable payment

The US Federal Trade Commission contends that a district court got it wrong in finding that Forest Laboratories, Inc. ’s side deals with generic manufacturers did not constitute unjustifiable payment

The US Food and Drug Administration approved modifications to the Risk Evaluation and Mitigation Strategy for mifepristone that permit retail pharmacists, as well as online pharmacists, to be certifie

A month after [Vitamin Shoppe Inc.]’s stock ticker was removed from listings with its acquisition by an investment firm, the nutrition, health and wellness manufacturer and retailer takes two steps to